Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Semira Sheikh

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|August 29, 2019
Pembrolizumab for the treatment of diffuse large B-cell lymphomaSemira Sheikh, John Kuruvilla
Expert Review of Hematology|November 25, 2010
Erythropoiesis-stimulating agents for anemic patients with cancerSemira Sheikh, Tim J Littlewood
Biomedicines|August 26, 2022
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and PerspectivesSemira Sheikh, Denis Migliorini, Noémie Lang
Future Oncology (London, England)|September 3, 2020
Belantamab mafodotin in the treatment of relapsed or refractory multiple myelomaSemira Sheikh, Eyal Lebel, Suzanne Trudel
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Prodrugs and prodrug-activated systems in gene therapySemira Sheikh, Daniel Ernst, Armand Keating
Critical Reviews in Oncogenesis|March 10, 2015
Deacetylation of chromatin and gene expression regulation: a new target for epigenetic therapyHeidi Olzscha, Semira Sheikh, Nicholas B La Thangue
Biomedicines|June 28, 2023
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative ReviewSarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
HDAC InhibitorsHeidi Olzscha, Mina E Bekheet, Semira Sheikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
COVID-19 Testing in Patients with Cancer: Does One Size Fit All?Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, et al.
Cancer Research|October 14, 2016
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent MechanismMaria New, Semira Sheikh, Mina Bekheet, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|August 29, 2019
Pembrolizumab for the treatment of diffuse large B-cell lymphomaSemira Sheikh, John Kuruvilla
Expert Review of Hematology|November 25, 2010
Erythropoiesis-stimulating agents for anemic patients with cancerSemira Sheikh, Tim J Littlewood
Biomedicines|August 26, 2022
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and PerspectivesSemira Sheikh, Denis Migliorini, Noémie Lang
Future Oncology (London, England)|September 3, 2020
Belantamab mafodotin in the treatment of relapsed or refractory multiple myelomaSemira Sheikh, Eyal Lebel, Suzanne Trudel
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 8, 2021
Prodrugs and prodrug-activated systems in gene therapySemira Sheikh, Daniel Ernst, Armand Keating
Critical Reviews in Oncogenesis|March 10, 2015
Deacetylation of chromatin and gene expression regulation: a new target for epigenetic therapyHeidi Olzscha, Semira Sheikh, Nicholas B La Thangue
Biomedicines|June 28, 2023
Efficacy of Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Narrative ReviewSarah Perdikis-Prati, Semira Sheikh, Antonin Bouroumeau, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 2, 2016
HDAC InhibitorsHeidi Olzscha, Mina E Bekheet, Semira Sheikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2020
COVID-19 Testing in Patients with Cancer: Does One Size Fit All?Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, et al.
Cancer Research|October 14, 2016
TLR Adaptor Protein MYD88 Mediates Sensitivity to HDAC Inhibitors via a Cytokine-Dependent MechanismMaria New, Semira Sheikh, Mina Bekheet, et al.
Pageof 2